Shanghai Children's Medical Center is a children's hospital in Shanghai, China, with the rank of "Grade 3, Class A", the highest level of hospital classification in China. It is a university hospital affiliated to the School of Medicine, Shanghai Jiao Tong University.

During the past decade, Shanghai Childrens Medical Center conducted 87 clinical trials. In the 10-year time frame, 87 clinical trials started and 7 clinical trials were completed, i.e. on average, 8% percent of trials that started reached the finish line to date. In the past 5 years, 44 clinical trials started and 5 clinical trials were completed. i.e. 11.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Shanghai Childrens Medical Center" #1 sponsor was "Shanghai Children's Medical Center" with 18 trials, followed by "Shanghai Jiao Tong University School of Medicine" with 14 trials sponsored, "Children's Hospital of Fudan University" with 10 trials sponsored, "GeneScience Pharmaceuticals Co., Ltd." with 9 trials sponsored and "Actelion" with 9 trials sponsored. Other sponsors include 36 different institutions and companies that sponsored additional 32 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Shanghai Childrens Medical Center" #1 collaborator was "Shanghai Children's Medical Center" with 16 trials as a collaborator, "Shanghai Children's Hospital" with 13 trials as a collaborator, "The Children's Hospital of Zhejiang University School of Medicine" with 8 trials as a collaborator, "Children's Hospital of Fudan University" with 7 trials as a collaborator and "The First Affiliated Hospital with Nanjing Medical University" with 6 trials as a collaborator. Other collaborators include 125 different institutions and companies that were collaborators in the rest 109 trials.

According to Clinical.Site data, the most researched conditions in "Shanghai Childrens Medical Center" are "Child Development" (4 trials), "Congenital Heart Disease" (4 trials), "Dwarfism" (4 trials), "Pulmonary Arterial Hypertension" (4 trials) and "Congenital Heart Defects" (3 trials). Many other conditions were trialed in "Shanghai Childrens Medical Center" in a lesser frequency.

Most popular intervention types in "Shanghai Childrens Medical Center" are "Drug" (50 trials), "Other" (17 trials), "Behavioral" (6 trials), "Biological" (6 trials) and "Device" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "PEG-somatropin" (3 trials), "Soticlestat" (3 trials), "distilled water" (3 trials) and "Behavioral sleep intervention" (2 trials). Other intervention names were less common.

The vast majority of trials in "Shanghai Childrens Medical Center" are 95 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Shanghai Childrens Medical Center". 8 are not yet recruiting, 29 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 32 completed trials in Shanghai Childrens Medical Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Shanghai Childrens Medical Center, 2 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 28 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 26 trials that are defined as “Not Applicable".